Clinical trial
Randomized, Double-Blind, Cross-Over, Vehicle Controlled Evaluation of Topical Encapsulated Benzoyl Peroxide on the Skin Microbiome and Skin Biophysical Properties
NCT05675501 is registered in ClinicalTrials.gov with Sol-Gel Technologies, Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Double-Blind, Cross-Over, Vehicle Controlled Evaluation of Topical Encapsulated Benzoyl Peroxide on the Skin Microbiome and Skin Biophysical Properties
- Lead sponsor
- Sol-Gel Technologies, Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 10, 2020
- Completion date
- July 15, 2021
- Enrollment
- 31 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
papulopustular rosacea